BioCryst Pharmaceuticals, Inc.
Crystalline salts of a plasma kallikrein inhibitor

Last updated:

Abstract:

Disclosed are crystalline salts of Compound I, methods of preparing them, and related pharmaceutical preparations thereof. Also disclosed are methods of treatment using the crystalline salts of the invention. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

6 Feb 2020

Issue date:

14 Sep 2021